Effect of Lipoprotein-X on lipid metabolism in rat kidney

被引:0
作者
O Karmin
May Ly
Ding Z. Fang
Jiri Frohlich
Patrick C. Choy
机构
[1] St. Paul's Hospital,Department of Pathology and Laboratory Medicine, University of British Columbia, Atherosclerosis Specialty Laboratory
[2] University of Manitoba,Department of Biochemistry and Molecular Biology
来源
Molecular and Cellular Biochemistry | 1997年 / 173卷
关键词
Lipoprotein-X; LCAT deficiency; kidneyperfusion; cholesterol; choelsteryl esters; phosphatidycholine;
D O I
暂无
中图分类号
学科分类号
摘要
Lipoprotein-X (Lp-X) is found in the plasma of patients with familiallecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. Themajority of the patients with this disorder develop progressiveglomerulosclerosis. In this study, the effect of Lp-X on lipid metabolism inperfused rat kidney was investigated. Lp-X was isolated from plasma ofpatients with familial LCAT deficiency by sequential ultracentrifugation andgel filtration column chromatography. Rat kidneys were perfused for 1-2 hwith Krebs-Henseleit buffer containing 20 µM [1-14C]acetate or 20µM [Me-3H]choline. In the presence of Lp-X, no significant differencein the incorporation of radioactivity into triglycerides, cholesterol,phosphocholine, CDP-choline and sphingomyelin was observed. However,incorporation of radioactivity into cholesteryl esters andphosphatidylcholine was significantly elevated in Lp-X perfused kidneys. Thecontents of cholesterol, cholesteryl esters and phosphatidylcholine werealso significantly increased in Lp-X perfused kidneys. The increase in lipidcontent in the Lp-X perfused kidney is attributed to the direct depositionof Lp-X lipids into the organ. The increase in the labelling of cholesterylesters was attributed to the increase of available substrate (cholesterol)for the acyl-CoA:cholesterol acyltransferase (ACAT) reaction. The increasein phosphatidylcholine labelling was caused by a reduced turnover of thenewly synthesized labelled phosphatidylcholine during Lp-X perfusion.
引用
收藏
页码:17 / 24
页数:7
相关论文
共 113 条
[1]  
Torsvik H(1972)Identification of the abnormal cholestatic lipoprotein (Lp-X) in familial lecithin:cholesterol acyltransferase deficiency FEBS Lett 24 165-167
[2]  
Berg K(1974)Plasma lipoproteins in patients with familial plasma lecithin:cholesterol acyltransferase (LCAT) deficiency–studies on the apolipoprotein composition of isolated fractions with identification of Lp-X Horm Metab Res Suppl 4 6-11
[3]  
Magnani HN(1975)Quantitative studies of lipoprotein-X in familial lecithin:cholesterol acyltransferase deficiency and during cholesterol esterification Clin Chem Acta 59 109-119
[4]  
McConathy WJ(1993)Familial lecithin:cholesterol acyltransferase deficiency: Further resolution of lipoprotein particle heterogeneity in the low density interval Atherosclerosis 104 195-212
[5]  
Alaupovic P(1967)Familial plasma lecithin:cholesterol acyltransferase deficiency. Biochemical study of a new inborn error of metabolism Scand J Clin Lab Invest 20 231-243
[6]  
Gjone E(1993)Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT(tyr83-stop) and LCAT(tyr156-asn) J Lipid Res 34 49-58
[7]  
Seidel D(1988)Plasma lipoprotein abnormalities in heterozygotes for familial lecithin: cholesterol acyltransferase deficiency Metabolism 37 3-8
[8]  
Gjone E(1973)Familial plasma lecithin:cholesterol acyltransferase (LCAT) deficiency: Ultrastructural aspects of a new syndrome with particular reference to lesions in the kidneys and the spleen Acta Pathol Microbiol Scand Section A 81 681-697
[9]  
Blomhoff JP(1974)Possible association between an abnormal low density lipoprotein and nephropathy in lecithin:cholesterol acyltransferase deficiency Clin Chim Acta 54 11-18
[10]  
Geisen HP(1974)Familial lecithin:cholesterol acyltransferase deficiency: Studies on lipid composition and morphology of tissues J Clin Lab Invest 33 93-100